Cytokines and CD8 T cell immunity during respiratory syncytial virus infection

Megan E Schmidt1, Steven M Varga2

  • 1Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, USA.

Cytokine
|July 23, 2018
PubMed

Insights

Respiratory syncytial virus (RSV) infection in infants poses a significant health risk. This review explores CD8 T cell responses and cytokine regulation in RSV, crucial for understanding viral clearance and immunopathology.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Respiratory syncytial virus (RSV) is a major cause of infant lower respiratory tract infections and hospitalizations.
  • Despite the clinical burden, no effective RSV vaccine currently exists.
  • CD8 T cells play a dual role in RSV infection, mediating viral clearance but also potentially causing immunopathology.

Purpose of the Study:

  • To review current literature on CD8 T cell responses to RSV.
  • To examine the functions of cytokines produced by CD8 T cells during RSV infection.
  • To discuss the regulatory mechanisms of CD8 T cell activation and effector functions.

Main Methods:

  • Literature review of studies on CD8 T cell responses in RSV infection.
  • Analysis of the roles of cytokines such as IFN-γ, TNF, IL-10, and IL-4.
  • Examination of regulatory pathways influencing CD8 T cell activity.

Main Results:

  • CD8 T cells produce cytokines like IFN-γ and TNF, aiding viral clearance but also contributing to immunopathology.
  • Cytokines such as IL-10 and IL-4 are critical in regulating CD8 T cell effector functions.
  • Understanding these cytokine-mediated regulatory mechanisms is key to managing RSV-induced immune responses.

Conclusions:

  • CD8 T cell responses are central to both protection and pathology in RSV infections.
  • Cytokine-mediated regulation is essential for balancing protective immunity and preventing detrimental inflammation.
  • Further research into these regulatory pathways may inform the development of novel therapeutic strategies for RSV.